Ophiopogonin D Prevents H2O2-induced Injury in Primary Human Umbilical Vein Endothelial Cells

Jinchun Qian,Fengrong Jiang,Bin Wang,Yang Yu,Xu Zhang,Zhimin Yin,Chang Liu

DOI: https://doi.org/10.1016/j.jep.2010.01.031

IF: 5.195

2010-01-01

Journal of Ethnopharmacology

Abstract:Aim of the study. Vessel endothelium injury caused by reactive oxygen species (ROS) including H2O2 plays a critical role in the pathogenesis of cardiovascular disorders Therefore, drug targeting ROS elimination has highly clinical values in cardiovascular therapy The plant of Radix Ophiopogon japonicus is a traditional Chinese herbal medicine that has been commonly used for prevention and treatment of cardiovascular diseases for a long history. However, the effective component mediating its beneficial effects remains unknown In the present study, we investigated the action of Ophiopogonin D (OP-D), one of the most bioactive components of Radix Ophiopogon japonicus, in an endothelial injury model induced by H2O2Materials and methods. Primarily cultured human umbilical vein endothelial cells (HUVECs) were pre-treated with increased doses of OP-D overnight and then challenged with H2O2 The protective effects of OP-D against H2O2 were evaluatedResults We found that OP-D inhibited mRNA levels of antioxidant, inflammatory and apoptotic genes in a dose-dependent manner in HUVECs H2O2-induced lipid peroxidation and protein carbonylation were reduced by OP-D pretreatment Mitochondria! ROS generation and cell apoptosis were also attenuated in OP-D pretreated cells In addition, OP-D restored cellular total antioxidative capacity and inhibited the release of inflammatory cytokines Furthermore, OP-D suppressed the enzymatic activity of catalase. HO-1, and caspases. Finally, OP-D blocked activation of NF-kappa B and ERK signaling cascades.Conclusion Our findings provide the first evidence that OP-D plays a protective role as an effective antioxidant in H2O2-induced endothelial injury Ophiopogonin D can be therefore developed as a novel drug for the therapy of cardiovascular disorders (C) 2010 Elsevier Ireland Ltd All rights reserved